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Abstract
Background: Laparoscopic procedure is a rapid developed technique in colorectal surgery. In this investigation we
aim at assessing the diversities of short-term and medium-term clinical outcomes of laparoscopic-assisted versus
open surgery for colorectal cancer.
Methods: A total number of 519 patients with non-metastatic colorectal cancer were enrolled for this study. The
patients underwent either laparoscopic-assisted surgery (LAP) (n = 254) or open surgery (OP) (n = 265). Surgical
techniques, perioperative managements and clinical follow-ups were standardized. Short-term perioperative data
and medium-term recurrence and survival were compared and analyzed between the two groups.
Results: There were no differences in perioperative parameters between the two groups except in regards to a trend
of faster recovery in laparoscopic procedures. There was no statistically significant difference in postoperative
complications, reoperation rate, or perioperative mortality. Statistically significant differences in a faster return of
gastrointestinal function and shorter hospital stay were identified in favor of laparoscopic-assisted resection. In colon
and rectal cancer cases separately, the overall survival, cancer-free survival and recurrence rate were similar in two
groups. There was also no tendency of significant differences in overall survival, cancer-free survival and recurrence in
stage I-II and stage III patients in two cancer categories between the two groups, respectively. pT, lymph node
metastasis, and clinical stage were independent predictors of overall death risk, while pT, pN, lymph node metastasis
and clinical stage were found to be the independent predictors of recurrence risk in enrolled patients database.
Conclusions: Laparoscopic-assisted procedure has more benefits on postoperative recovery, while has the same
effects on medium-term recurrence and survival compared with open surgery in the treatment of non-metastatic
colorectal cancer.
Background
Colorectal cancer has gradually become one of the most
significant leading causes of death from malignancies
world-wide, especially in China. Surgical management is
still the mainstay of the treatment [1,2]. Conventional
open surgery is reported with significant morbidity and
a long recovery period. With the laparoscopic
techniques applied to the surgical field for colorectal
diseases, laparoscopic colorectal surgery was first per-
formed in Japan in 1992, very soon after its initial
description by Jacobs et al [3,4]. In 1993, the first
laparoscopic colectomy was successfully performed in
China. Since then, laparoscopic surgery has been widely
performed for various benign colorectal diseases [5-8],
and furthermore, colorectal cancer.
Laparoscopic colorectal surgery is technically compli-
c a t e da si ti n v o l v e sa l m o s ta ll advanced laparoscopic
techniques, such as mobilization, intracorporeal division,
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any medium, provided the original work is properly cited.dissection of major vessels, and anastomosis. There is a
steep learning curve to achieve advanced laparoscopic
skills. But when the learning phase has been conquered,
the benefits of laparoscopic surgery have been suggested
with respect to decreased morbidity, decreased pain, fas-
ter recovery, shorter hospital stay and possibly reduced
immunosuppression, comparing with open surgery
[9-12].
However, behind the great success of laparoscopic col-
orectal surgery, there are still many questions that
remain unclear, including whether laparoscopic colorec-
tal cancer surgery is radical or not, seldom reported
superior short-term outcomes. Laparoscopic colorectal
surgery is still not considered standard treatment [13].
There are also controversies with potential port site
recurrence after curative resection of tumor, not to
mention too much economical costs.
In this article, we investigated the short-term and
medium-term clinical outcomes of laparoscopic surgery
versus open surgery for colorectal cancer over a period
of 5 years in our center, aiming at investigating whether
the laparoscopic surgery has any advantages for the
patients with colorectal cancer or not.
Methods
Patient selection
Between January 2006 and June 2009, patients who
underwent radical colorectal surgery for colorectal can-
cer in Affiliated First People’s Hospital, Shanghai Jiao
Tong University were consecutively enrolled in this
study. Both open surgeries (OP) and laparoscopic-
assisted surgeries (LAP) were performed by two stable
surgical teams, respectively. No selection criteria were
used to allocate patients to either a laparoscopic or an
open operation. Patients were assigned to each surgical
team (open or laparoscopic) according to their target
dates for treatment and operating theatre availability. A
minority of patients who wished to be operated laparos-
copically were accommodated whenever possible. The
trial received approval from local research ethics com-
mittee, and written informed consent was obtained from
all patients before the investigation.
All patients enrolled accepted preoperative laboratory
examination including tumor markers screening, coagu-
lation test, chest x-ray, abdominal ultrasound, colono-
scopy and if necessary, CT scan of the abdomen and
pelvis. Endoscopic applications of metal clips for tumor
localization, as well as intra-operative colonoscopic
orientations were performed selectively. All patients
were confirmed to have a malignant tumor after post-
operative pathologic examination. Postoperative clinical
staging after pathologic examination was based on the
UICC cancer staging manual (2007). None of the
patients had accepted preoperative radiotherapy or
chemotherapy; out of the patients who were pathologi-
cally diagnosed as stage III, all accepted adjuvant che-
motherapy with oxaliplatin and 5-fluorouracil for 6
months postoperatively. Exclusion criteria were: in situ
or metastatic disease, emergency presentation, morbid
obesity (defined as body mass index, i.e. BMI > 35 kg/
m
2), a classification V physical status according to the
American Society of Anesthesiologists (ASA), associated
gastrointestinal disease that required extensive operative
evaluation or intervention, pregnancy or malignant dis-
ease in the past 5 years (except superficial squamous or
basal cell carcinoma of the skin or in situ cervical
cancer).
Preoperative preparations and operation procedures
All patients had oral administration of gentamicin and
metronidazole, 3 times a day for 3 days before surgery.
Polyethylene glycol-electrolyte solution or magnesium
sulfate was given one day before the surgery for bowel
preparation. Other preoperative preparations were
standardized, as followed for traditional abdominal
surgeries.
Laparoscopic-assisted resection involved mobilization
of the colon, visualization of critical structures, and
intracorporeal vascular ligation. A standard total mesor-
ectal excision (TME) procedure was essential for rectal
cancer resection. A small abdominal incision was
required to remove the specimen. Anastomosis was per-
formed either through the small incision for right-hemi,
transverse and left-hemi colon cancer, or laparoscopi-
cally with a double-stapling technique, for sigmoid and
rectal cancer. If the tumor was located so close to the
dentation line that anal-saving could not guarantee the
radical standards and operation safety, the Hartmann &
Bacon procedures were performed. In the majority of
cases, the operation was performed utilizing a lateral to
medial approach. In this study, an incision longer or dif-
ferent to that planned was used to determine a conver-
sion. Conversion to open colectomy was at the
discretion of the surgeon based on concerns regarding
patient safety, technical difficulties, or associated unex-
pected conditions requiring treatment by laparotomy.
Conversions were recorded and analyzed as part of the
laparoscopic arm of the study, but were excluded for
further analysis. Open procedures were performed
according to the standard techniques followed by the
operating surgeon. All operations achieved a standard
D2 lymph node dissection according to the Guidelines
of Radical Laparoscopic Colorectal Cancer Surgery
(2006, 2008) established by the Study Group of Laparo-
scopic and Endoscopic Surgery Affiliated to Chinese
M e d i c a lA s s o c i a t i o n ,a sw e l la st h eG e n e r a lR u l e sf o r
Clinical and Pathological Studies on Cancer of the
Colon, Rectum and Anus, 5
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Rectum.
Perioperative surveillance, postoperative managements
and follow-up evaluation
Demographic and operative data were obtained regard-
ing age, gender, BMI, ASA score, comorbidities, history
of previous abdominal surgery, tumor location, surgical
intervention, operative time, blood loss, maximum inci-
sion length, sample length, proximal and distal margin
length, number of retrieved lymph nodes and lymph
node metastases, tumor size, pathological differentiation
and clinical stage. Postoperative data included analgesic
usage, Visual Analog Scales (VAS) score, peristalsis
recovery time, time until flatus, time until off-bed, time
until first liquid and semi-liquid intake, postoperative
duration of hospital stay and total time of hospital stay,
were recorded.
Patients enrolled in the present study were managed
postoperatively by the same group of surgeons. Patients
in both groups were supported by infusions in the very
first several hours after surgery. After confirmation of
the peristalsis recovery, liquid diet was supplied. Semi-
liquid diet was considered suitable for patients after
report of flatus. For pain control, patients were given
patient-controlled anesthesia (PCA) or short-acting
drugs according to their own aspirations. Prophylactic
antibiotics were used during 72 hours after surgery;
however, if there was any indication of infection, this
time was prolonged. The catheter was removed as early
as possible except for patients with tumors located in
the lower region of the rectum. The peritoneal drain
was removed on POD7, only if no leakage or hemor-
rhage was confirmed, as well as the patient had taken
semi-liquid food and had reported a formed stool. In
patients with postoperative complications, the manage-
ment was almost the same in both treatments groups,
respectively. All patients were followed-up after being
discharged from the hospital, according to a pre-estab-
lished protocol. This included recording of medical his-
tory, physical examination, and laboratory studies such
as, serum carcinoembryonic antigen (CEA) and carbohy-
drate antigen 19-9 (CE19-9) levels, which were assessed
1 month after surgery and every 3 months thereafter. At
each patient visit, symptoms were recorded and wound
scars examined for subcutaneous metastasis. Either
ultrasonography or CT scan of the abdomen, in addition
to chest X-ray was performed every 6 months whereas
total colonoscopy was performed every year. When
colonoscopy was incomplete, a combination of sigmoi-
doscopy and barium enema methods was undertaken.
Recurrences were histologically confirmed and classified
as distant metastasis, locoregional relapse (tumor growth
restricted to the anastomosis or the region of primary
operation), and incision/port-site metastasis. The last
date for follow-ups was March, 2011.
Statistical analysis
Data were collected prospecti v e l yu s i n gac o m p u t e r i z e d
data base according to pre-study Power calculation.
Quantitative data was given as a mean ± standard devia-
tion, and analyzed using Student’st - t e s t .C o u n td a t a
between LAP and OP groups was assessed by Mann-
Whitney, Chi-Square or Fisher’s exact test as appropri-
ate. Comparisons between the two groups were made
on an intention-to-treat basis; thus, patients in the LAP
group converted to the open procedure were not
excluded from the analysis. Time to: (1) last follow-up
evaluation, (2) treatment failure or (3) death was mea-
sured from the date of operation.
Recurrence and overall survivals were evaluated using
the Kaplan-Meier method and compared with the log-
rank test. Analysis of predictive factors of survival was
performed. Variables analyzed univariately were, age,
g e n d e r ,B M I ,A S As c o r e s ,p r e o p e r a t i v ec o m o r b i d i t i e s ,
tumor location, intervention, surgical procedures, tumor
s i z e ,p T ,p N ,p a t h o l o g i c a ld i f ferentiation, lymph nodes
metastasis, clinical stage, and postoperative complica-
tions. Variables associated with recurrence or survival,
were then used for multivariate analysis using a stepwise
Cox proportional-hazards regression model. Statistical
significance was defined as P < 0.05. All calculations
were performed by using the SPSS software package ver-
sion 12.0 (SPSS Inc., Chicago, IL).
Results
A total of 519 patients were enrolled and analyzed in
this trial: 254 underwent laparoscopic-assisted colorectal
resection and 265 were treated with open colorectal
resection. There was no statistically significant difference
found in the majority of the demographic parameters
between the two patient populations (Table 1).
Operative Parameters
There was no statistically significant difference in the
operative time between the groups. Furthermore, we
observed decreased blood loss during laparoscopic sur-
gery, which was statistically significant (P value?).
Patients in the LAP group had significantly shorter sur-
gical incisions (P = 0.000). Eight cases (3.0%) were con-
verted from laparoscopic to open surgery. Reasons for
conversion were severe local invasion (2 cases, 0.8%)
and adhesion (6 cases, 2.3%) (Table 1).
Pathological Evaluation
The majority of tumors were located in the rectum,
right-hemi colon, and sigmoid colon, which is consistent
with the colorectal epidemiology scenario in China, with
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dominant tumor type was adenocarcinoma with the
majority being moderately differentiated in both groups
(P = 0.222) (Table 2).
Resection margins were measured in fresh specimens
after surgery, without fixation with formalin (Table 2).
The proximal margin in colon cancer group were
12.7 ± 6.8 cm in LAP and 11.4 ± 4.1 cm in OP group
respectively (P = 0.000). The distal margin in rectal can-
cer group were 4.8 ± 3.1 cm in LAP and 4.0 ± 1.7 cm in
OP group (P = 0.052), respectively. The postoperative
pathological confirmation indicated that there was no
case of positive resection margins. Thus, no patient was
required to return for a further resection to ensure ade-
quate margins were obtained. Fresh resection lengths
were 26.3 ± 10.5 cm in the LAP group and 25.4 ± 8.9
cm in the OP group (P = 0.302).
The lymph nodes were retrieved from each
sample after fixation, by the standby surgeon and
pathologist and reconfirmed to be metastatic using
Table 1 Demographic Data and Intraoperative Data
LAP
(n = 254)
OP
(n = 265)
P
n%n %
Age (Years, mean ± SD) 67.5 ± 10.8 66.0 ± 12.1 0.137
Gender Male 138 54.3 126 47.5 0.136
Female 116 45.7 139 52.5
BMI (kg/m
2, mean ± SD) 23.4 ± 4.1 23.5 ± 3.9 0.622
ASA Score 1 17 6.7 27 10.2 0.222
2 148 58.3 160 60.4
3 83 32.7 69 26.1
4 6 2.3 9 3.3
Abdominal Operation History 1.000
No 194 76.4 202 76.2
Yes 60 23.6 63 23.8
Preoperative Comorbid Diseases 0.333
No 109 42.9 125 47.2
Yes 145 57.1 140 52.8
Cardiovascular 113 111
Respiratory 10 11
Hepatic Cirrhosis 0 1
Renal Failure 4 6
Cerebral Infarction 7 8
Diabetes 39 30
Autoimmunal 1 1
Others 17 15
Intervention Right Colectomy 70 27.6 72 27.2 0.906
Transverse Colectomy 3 1.2 6 2.2
Left Colectomy 16 6.2 15 5.7
Sigmoidectomy 67 26.4 68 25.7
HAR 51 20.1 56 21.1
LAR 17 6.7 26 9.8
APR 27 10.6 19 7.2
Hartmann 1 0.4 3 1.1
Bacon 2 0.8 0 0.0
Conversions to Open
a 83/ /
Operative Time (min, mean ± SD) 135.6 ±
40.0
131.2 ± 46.0 0.307
Blood Loss (ml, mean ± SD) 101.5 ±
70.8
104.7 ±
118.8
0.002
Maximum Incision (cm, mean ± SD) 4.3 ± 1.1 13.6 ± 2.3 0.000
BMI, Body Mass Index; ASA, American Society of Anesthesiologists; HAR, High
Anterior Resection; LAR, Low Anterior Resection; APR, Abdomioperineal
Resection; a, 1 HAR, 1 LAR, 1 Sigmoid Colostomy, 2 Right Colectomy, and 3
Sigmoidectomy; All conversions on account of severe local invasion and
adhesion (Excluded from Laparoscopic group)
Table 2 Pathological Parameters
LAP
(n = 254)
OP
(n = 265)
P
n%n %
Location Right-hemi Colon 70 27.6 72 27.2 0.896
Transverse Colon 3 1.2 6 2.2
Left-hemi Colon 16 6.2 15 5.7
Sigmoid Colon 65 25.6 68 25.7
Rectum 100 39.4 104 39.2
Tumor Size (cm, mean ± SD) 4.7 ± 1.7 4.8 ± 1.9 0.579
Proximal Margin for colon cancer (cm)
a 12.7 ± 6.8 11.4 ± 4.1 0.000
Distal Margin for colon cancer (cm)
a 10.7 ± 6.7 9.8 ± 5.7 0.189
Proximal Margin for rectum cancer (cm)
b 11.4 ± 4.3 11.7 ± 4.7 0.573
Distal Margin f for rectum cancer(cm)
b 4.8 ± 3.1 4.0 ± 1.7 0.052
Total Sample Length(cm) 26.3 ± 10.5 25.4 ± 8.9 0.302
Lymph Nodes Retrieved 12.0 ± 6.9 11.4 ± 7.1 0.327
Pathological Results
Differentiation 0.222
Well-differentiated 51 20.1 53 20.0
Moderate-differentiated 172 67.7 166 62.6
Poor-differentiated 16 6.3 17 6.5
Mucinous 15 5.9 29 10.9
pT 0.362
pT1 33 13.0 27 10.2
pT2 63 24.8 52 19.6
pT3 75 29.5 107 40.4
pT4 83 32.7 79 29.8
pN 0.661
pN0 104 40.9 117 44.2
pN1 83 32.7 81 30.6
pN2 67 26.4 67 25.3
Lymph Nodes Metastasis 0.478
Yes 150 59.1 148 55.8
No 104 40.9 117 44.2
TMN Stage 0.286
I 26 10.2 17 6.4
II 103 40.6 111 41.9
III 125 49.2 137 51.6
aLaparoscopy group n = 154, open group n = 161.
bLaparoscopy group n = 100, open group n = 104.
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from the LAP group were 12.0 ± 6.9, while from the
group treated with open surgery were 11.4 ± 7.1 (P =
0.327). There were no significant differences in pT,
pN, lymph node metastasis or overall TNM staging (P
= 0.362, 0.661, P = 0.478, P = 0.286) (Table 2).
Perioperative Complications and Reoperations
No significant difference was found in the number of
adverse events during the operation procedures (Table
3). Of the adverse events that occurred during laparo-
scopic procedures, there was: 1 massive hemorrhage
(approximately 1500 ml, requiring blood transfusion
during the surgery), 1 left ureter injury during sigmoi-
dectomy, 1 duodenum injury during right colectomy, 2
instrument disorders, and 1 subcutaneous emphysema.
During the open surgery, 1 massive hemorrhage
(approximately 1000 ml, requiring blood transfusion
during the surgery), 1 left ureter injury during HAR
(High Anterior Resection) and 1 stapler-failure causing
leakage during LAR (Low Anterior Resection) were
reported.
The number of patients with at least 1 intraoperative
complication was not significantly greater among the
laparoscopically treated patients as expected: 6 (2.4%)
versus 3 (1.1%) (P = 0.330). Moreover, the number of
patients with at least 1 postoperative complication was
not significantly different between the 2 groups: 33
(12.9%) for laparoscopic surgery versus 34 (12.8%) for
open surgery (P = 0.530). All cases of anastomotic leak-
age occurred only in LAR patients in both groups.
Among the laparoscopically treated group, one each of 4
rare complications: lymphatic fistula, deep vein throm-
bosis, common peroneal nerve injury and pneumoperi-
toneum-related acidosis, were seen. These were the
typical adverse events of laparoscopic surgery. In the OP
group one case each of urinary retention and recto-vagi-
nal fistula were reported.
There was no statistically significant difference in the
rate of reoperation between the 2 groups: 7 (2.8%) for
laparoscopic surgery versus 3 (1.1%) for open surgery (P
= 0.213). There were 4 (1.4%) anastomotic leaks in the
LAP group with reoperation compared with a single
case (3.4%) reported from the OP group (P = 0.173).
Four reoperation cases among laparoscopically treated
patients included 1 Hartmann and 3 transverse colos-
tomies, compared to 1 case of transverse colostomy
requiring reoperation in the OP group. Three additional
reoperations among LAP treated patients were: re-
colostomy for colostomy stoma necrosis, Hartmann for
anastomotic hemorrhage, laparotomy for anastomotic
obstruction. Two further reoperations in the patient
group who received open surgery treatment were asso-
ciated with abscess drainage for pelvic-perianal abscess
and reconstruction for recto-vaginal fistula.
Perioperative Recovery and Mortality
The patients in the LAP group showed statistically sig-
nificant faster recovery than the OP group. 66.1% (168/
254) of patients in the LAP group did not need analge-
sic for pain-control after surgery, and only 20.5% (52/
254) of patients need PCIA (patient controlled intrave-
nous analgesia) for pain-control. Most of the patients in
the OP group demanded PCIA for after-surgery pain-
control as a requisite treatment, and only 19.6% (52/
265) of patients could pass the recovery period peace-
fully without any analgesic. Laparoscopic colorectal sur-
gery obviously caused significantly less pain for patients
(P = 0.008). The average time after which the patient
got off from bed was 2.8 ± 1.8 days for LAP group ver-
sus 4.7 ± 3.1 days for OP group (P = 0.000). Peristalsis
Table 3 Perioperative Complications for Colorectal
Cancer
LAP
(n = 254)
OP
(n = 265)
P
n%n%
Intraoperative Complications 6 2.4 3 1.1 0.330
Massive Hemorrhage (> 1000 ml) 1 1
Organ Injury 2 1
Equipment Disorders 2 0
Others 1
a 1
b
Post-operative Complications 33 12.9 34 12.8 0.530
Ileus 6 5
Anastomotic Hemorrhage 1 0
Abdominal Hemorrhage 1 1
Peritonitis/Septic Shock 1 1
Anastomotic Leakage 5 4
Pelvic Abscess 2 3
Wound Infection 5 6
Incisional/Port Herniation 3 2
Cardiovascular Disorders 1 3
Respiratory Disorders 0 3
Renal Failure 0 2
Urinary Infection 2 1
Cerebral Disorders 1 1
Colostomy Stoma 1 0
Others 4
c 2
d
Re-operative cases 7
e 2.8 3
f 1.1 0.213
a 1 of Subcutaneous Emphysema.
b 1 of stapler leakage during LAR.
c 1 of Lymphatic Fistula, 1 of Deep Vein Thrombosis, 1 of Common Peroneal
Nerve Injury, 1 of Pneumoperitoneum-related Acidosis.
d 1 of Urinary Retention, 1 of Recto-vaginal Fistula.
e 1 Re-colostomy for Colostomy Stoma Necrosis, 1 Hartmann for Anastomotic
Hemorrhage, 1 Laparotomy for Anastomotic Obstruction, 1 Hartmann for
Leakage, 3 Transverse Colostomies for Leakage.
f 1 Abscess Drainage for Pelvic-perianal Abscess, 1 Transverse Colostomy for
Leakage, 1 Reconstruction for Recto-vaginal Fistula.
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total hospital stay were all significantly shorter in the
LAP group (P = 0.000). Regarding time to oral intake,
although the results showed a significantly earlier time
among the laparoscopically treated patients, actually this
time was found to be influenced by surgeon’se x p e r i -
ences and customs to a great extent. Since the two
groups were managed by different surgical teams respec-
tively, the variation in oral intake time had to be
excluded from the evaluation of postoperative recovery
(Table 4).
There were 2 cases of perioperative mortality in each
group, which was excluded from the follow-up investiga-
tion (Table 5). One laparoscopically treated patient died
due to complications arising from an anastomotic leak,
diagnosed as septic shock, which developed into multi-
ple organ disorder syndrome (MODS) leading to death
on POD#19. A second death recorded, was due to a
sudden cardiac arrest on POD#1. In the OP group, both
mortalities, on POD#6 and POD#7 respectively, were
reported to have cardiovascular causes.
Follow-up Recurrence and Survival
A 100% patient follow-up was achieved in the present
study. All patients were compliant with the proposed
postoperative surveillance protocol. The total follow-up
duration was from 8.2 to 62.5 months in the whole ser-
ies (8.2 to 62.5 months in the LAP group, and 10.4 to
62.5 months in the OP group). The median follow-up
times were 37.1 months and 36.7 months in the laparos-
copically operated and open surgically treated groups,
respectively.
In both colon and rectal cancer cases, there was no
difference in the overall mortality trend between the
two treatment groups (P = 0.113, 0.439). The number of
deaths, respectively, in the laparoscopically and open
surgically treated groups, among colon cancer cases was
33 patients (21.4%) versus 45 patients (28.0%), while
among rectal cancer cases was 25 patients (25.0%) ver-
sus 29 patients (27.9%) (Table 5).
According to the results of Kaplan-Meier analysis, in
colon cancer cases, the two treatment groups did not
have significant differences in overall survival (P =
0.305). When patients were stratified according to the
tumor stage, the probabilities of overall survival were
not significantly different between the two treatment
groups for stage I-II (P = 0.498) and stage III (P =
0.629) tumors (Figure 1). Consistent to our observation
in the colon cancer cases, among the rectal cancer
patients, the two treatment groups did not have signifi-
cant differences in overall survival (P = 0.954). When
patients were stratified according to the tumor stage,
the probabilities of overall survivals were not signifi-
cantly different in the LAP group compared with OP
group for stage I-II (P = 0.723) as well as stage III (P =
0.949) tumors (Figure 2).
In colon and rectal cancer cases, the tumor recurrence
rates tended to be similar in both treatment groups (P =
0.501, 0.482). In the colon cancer cohort, 44 patients
(28.6%) from the LAP group and 47 patients (29.2%)
from the OP group showed tumor recurrence. Tumor
recurrence was reported in 33 (33.0%) and 32 rectal
cancer patients (30.8%), respectively, from the laparosco-
pically and OP groups (Table 5). The overall cancer-free
survival duration according to Kaplan-Meier analysis
also showed similar results in the two cancer categories,
respectively (P = 0.973, 0.968) (Figures 3 and 4).
Prognostic Analyses
As indicated by the univariate analysis, pN, lymph node
metastasis, and clinical stage (P = 0.001, P = 0.000, P =
0.000, respectively) were found to be independent pre-
dictors of overall death risk, while tumor diameter, pT,
pN, lymph node metastasis and clinical stage (P = 0.044,
P = 0.008, P = 0.008, P = 0.002, P = 0.000, respectively)
were found to be independent predictors of recurrence
risk (Table 6).
However, the multivariate analysis indicated that pT,
lymph node metastasis, and clinical stage (P = 0.049, P
= 0.003, P = 0.000, respectively) were all independent
predictors of overall death risk, while pT, pN, lymph
node metastasis and clinical stage (P = 0.023, P = 0.015,
P = 0.005, P = 0.000, respectively) were found to be the
independent predictors of recurrence risk (Table 7).
Discussion
We report the Chinese experience of performing
laparoscopic-assisted colectomy for colorectal cancer.
Table 4 Postoperative Recovery
LAP
(n = 254)
OP
(n = 265)
P
n%n%
Analgesic Usage 0.000
No 168 66.1 52 19.6
Short-acting Drug 34 13.4 18 6.8
PCIA 52 20.5 195 73.6
VAS Score (NRS) on POD#1 (mean ± SD) 2.8 ± 1.6 3.2 ± 1.9 0.008
Off-bed (day, mean ± SD) 2.8 ± 1.8 4.7 ± 3.1 0.000
Peristalsis Recovery (day, mean ± SD) 1.8 ± 0.8 2.5 ± 1.2 0.000
Flatus (day, mean ± SD) 3.2 ± 1.6 4.3 ± 2.9 0.000
Liquid Intake (day, mean ± SD) 3.6 ± 2.1 5.3 ± 4.3 0.000
Semi-liquid Intake (day, mean ± SD) 6.1 ± 2.5 8.2 ± 4.7 0.000
Post-op Hospital Stay (day, mean ± SD) 9.8 ± 4.7 13.1 ± .7.2 0.000
Total Hospital Stay (day, mean ± SD) 17.6 ± 7.4 22.9 ± 9.3 0.000
PCIA, Patient Controlled Intravenous Analgesia, personalized prescription of
tramadol and fentanyl. VAS, Visual Analog Scales; NRS, Numerical Rating
Scales.
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and safe; patients had acceptable rates of complications
and conversion to open laparotomy, as well as reason-
ably short postoperative durations of stay, a large num-
ber of lymph node retrieval, and finally, similar survival
rates.
With the development of laparoscopic techniques,
along with the improvement of laparoscopic instru-
ments, a standard laparoscopic procedure for colorectal
cancer surgery has gradually become widely accepted,
and a radical cure resection seems feasible for laparo-
scopic surgeries. The present study showed that there
were no differences in the outcomes between the two
treatment groups. Apart from acquirement of a new
skill the laparoscopic surgeon being a factor, which can-
not be totally ignored, this was a straightforward com-
parison. Furthermore, there was no apparent
deterioration in the quality of surgery associated with
Table 5 Postoperative Recurrence and Survival for Colorectal Cancer
Colon Cancer P Rectal Cancer P
LAP (n = 154) OP(n = 161) LAP (n = 100) OP(n = 104)
n%n % n%n %
Overall Mortality 33 21.4 45 28.0 0.113 25 25.0 29 27.9 0.439
Cause of Death
Peri-operative Mortality 1
a 1
c 1
b 1
c
Tumor Progression 31 42 22 27
Others 1
d 2
e 2
f 1
g
Tumor Recurrence 44 28.6 47 29.2 0.501 33 33.0 32 30.8 0.482
Type of Recurrence
Locoregional Relapse 18 21 17 18
Metastasis 24 25 15 14
Incision/Port Metastasis 2 1 1 0
a 1 on POD#19 for septic shock (Excluded from Laparoscopic group for survival analysis).
b 1on POD#1 for cardiac arrest (Excluded from Laparoscopic group for survival analysis).
c 2 on POD#6, POD#7 respectively for cardiovascular accident (Excluded from Open group).
d 1 for traffic accident.
e 1 for unknown reason, 1 for cardiac infarction.
f 1for cerebral hemorrhage, 1 for cardiac infarction.
g 1 for cardiac infarction.
Figure 1 Survival Analysis in Colon Cancer Cases.T h e
laparoscopic-assisted group is represented by a continuous line and the
open surgery group is represented by a dotted line. The red lines
represent overall survival for all stages in the two groups (P = 0.305). The
green lines represent overall survival for stage I-II patients in the two
groups (P = 0.498). The blue lines represent overall survival for stage III
patients in the two groups (P = 0.629).
Figure 2 Survival Analysis in Rectal Cancer Cases.T h e
laparoscopic-assisted group is represented by a continuous line and
the open surgery group is represented by a dotted line. The red
lines represent overall survival for all stages in the two groups
(P = 0.954). The green lines represent overall survival for stage I-II
patients in the two groups (P = 0.723). The blue lines represent
overall survival for stage III patients in the two groups (P = 0.949).
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Page 7 of 12the introduction of laparoscopic resection, as stoma for-
mation and APR rates in rectal cancer remained
unchanged over time. The intraoperative comparison
between the two groups in our study indicated almost
similar operative time and complications, which was not
in keeping with other randomized controlled studies
[14-20]. The mean operating time for the laparoscopic-
assisted procedure was shorter in this study than in the
Multicentre Randomized Controlled trial - Conventional
versus Laparoscopic-Assisted Surgery In patients with
Colorectal cancer (MRC CLASICC) [14] trial but similar
to the Colon Carcinoma Laparoscopic or Open Resec-
tion (COLOR) [15,17] trial.
The number of lymph nodes harvested during the surgi-
cal procedure influences clinical staging of the tumor and
is not only influenced by the operative technique or the
extent of lymphadenectomy, but to an even greater extent
by pathological techniques involved in processing the spe-
cimens. Examining fewer than 12 lymph nodes in a speci-
men can result in under-staging [21]. Since the specimens
retrieved by either laparoscopic-assisted or open resection
were processed in different ways, it has been difficult to
compare the harvested lymph nodes in different studies.
Nevertheless, since the standard D2 lymph node dissection
was consistently followed for all operations, and the lymph
node was always collected by a permanent surgeon and a
permanent pathologist, a diminished bias during lymph
node collection was assured. Our final analysis confirmed
that there were no differences in lymph nodes harvested
between the LAP and OP groups in this study, with the
majority of patients having sufficient lymph nodes to be
collected for accurate staging.
In previous reports with data on resection margins,
none of the margins was found to be positive. Although
this is a remarkable finding, it can be explained by the
fact that most of these studies [22-27] only reported dis-
tal and proximal margins. No data on circumferential
margins were available from these studies. Results of the
primary analysis indicated that laparoscopic procedure
might have the ability to reach a better dissect field than
the open procedure, assuring the radical cure resection.
Among our patients, those who underwent laparo-
scopic procedure had significantly faster recovery than
those who underwent open surgery. LAP group patients
definitely need a smaller dose of analgesic than their
counterparts who received open surgery treatment. In
fact, most laparoscopic procedures seem to cause less
pain, so that analgesics are rarely necessary. It is
reported that some centers are in favor of the epidural
combined with general anesthesia during the operation.
Thus, usually the PCEA (patient controlled epidural
analgesia) and PCIA are both usual options of post-
operative pain-control procedures. Some reports con-
cluded that PCEA has greater advantages over PCIA
[28,29]. In our center, general anesthesia is used routi-
nely for laparoscopic surgery; PCIA is the choice only
for patient controlled pain-control procedures. However,
since the majority of LAP group patients did not require
analgesia, the pain-control method did not seem to be
an important parameter for laparoscopic colorectal
surgery.
Total hospital stay and postoperative hospital stay are
two important evaluation criteria for fast-recovery sur-
gery. The postoperative hospital stay for LAP and OP
group in the Multicentre Randomized Controlled trial -
MRC-CLASICC Trial was 9 days and 11 days, respec-
tively [14]; however, the Clinical Outcomes of Surgical
Therapy Study group (COST) Trial was 5.1 days and 5.6
days, respectively [22,23]. Length of hospital stay is an
indicator which can be easily affected by different con-
founding factors, such as geographic locations, reflecting
cultural and possibly financial reimbursement differ-
ences [30]. In our group, all stage III patients accepted
postoperative adjuvant chemotherapy. There was a set
of patients in both groups who could not be discharged
until the end of the first regimen of chemotherapy. This
undoubtedly extended the length of hospital stay for
these patients, thus introducing bias in the comparison
of hospital stay between the two groups. Thus, we calcu-
lated the actual hospital stay after eliminating any such
excess periods of stay during the investigation.
The anastamotic leakage rate in LAR patients is signif-
icantly higher in laparoscopically treated cases (5/17,
29%) than in the OP group (4/26, 15%). However, after
revisiting the data in the LAP group we discovered that
all the leakage occurred in early cases; this may be
Figure 3 Cancer-free Survival Analysis in Colon Cancer Cases.
The laparoscopic-assisted group is represented by a continuous line
and the open surgery group is represented by a dotted line. The
cancer-free survival for all colon cancer cases in the two groups
have no significant difference (P = 0.973).
Sun et al. BMC Gastroenterology 2011, 11:85
http://www.biomedcentral.com/1471-230X/11/85
Page 8 of 12explained as effect of learning curve. The investigation
enrolled these patients when our laparoscopic surgeon
was in the early stages of learning curve, which led to a
higher rate of complications. However, for the open sur-
gery, all enrolled patients were operated by a surgeon
with experience of more than 500 cases of open colorec-
tal cancer surgeries.
T h ec o n v e r s i o nr a t ei nt h i ss t u d yw a so n l y3 % ,w h i c h
was far lower than that reported in other trials. The
conversion rate from laparoscopic to open surgery was
17% in the COLOR trial [15,17], 25.4% in the COST
[22] and 29% in the MRC-CLASICC [14] trial.
The MRC-CLASICC trial included cases of both rectal
cancer and advanced stage cancer; 34% of patients with
cancer of the rectum compared with 25% of patients
with cancer of the colon underwent conversion from
laparoscopic to open procedure. The ALCCaS trial did
not include patients with rectal cancer [31]. It is also
worth noting that in the MRC-CLASICC trial the rate
of intraoperative conversions fell by the year of study
from 38% in the first year to 16% in the sixth year [14].
In our study, the laparoscopic procedures were all per-
formed by a single surgeon and the conversion cases all
reported in the early period. However, as time passed
the experience in the procedure increased. With stabili-
zation of the learning curve of the operating surgeon,
the conversion rate significantly reduced. Furthermore,
in our study stage IV patients were not included, and all
patients were found in preoperative evaluation to be sui-
table for laparoscopic procedure, thus the conversion
rate was lower than other trials. It was reported that
there was no difference when comparing conversions to
those completed in operative time, morbidity, length of
stay, costs, and readmission [32]. There was greater
blood loss, longer time to first bowel movement, longer
length of stay when converted cases were compared
with the cases completed with the laparoscopic-assisted
approach but no difference when compared with open
surgery [33].
Additionally, our study showed similar overall recur-
rence rate, as well as the survival rate between the two
groups. The number of patients that developed a recur-
rence at the site of the primary tumor during the fol-
low-up period of the study was similar to that after
laparoscopic and open surgery in other trials respec-
tively. Separate analyses for colon and rectal cancer
Figure 4 Cancer-free Survival Analysis in Rectal Cancer Cases.
The laparoscopic-assisted group is represented by a continuous line
and the open surgery group is represented by a dotted line. The
cancer-free survival for all rectal cancer cases in the two groups
have no significant difference (P = 0.968).
Table 6 Univariate Risk Evaluations for Recurrence and Survival
Factors Over-all Death Risk (n = 519) Recurrence Risk (n = 519)
Chi
2 P Chi
2 P
Gender 0.847 0.357 0.270 0.604
Age (years,≤65, > 65) 2.642 0.104 2.398 0.122
BMI (kg/m
2, ≤24, > 24) 0.451 0.502 0.128 0.721
ASA Score 1.675 0.642 2.996 0.392
Pre-op Comorbidities 2.460 0.117 1.672 0.196
Tumor Location 8.726 0.068 6.570 0.160
Intervention 12.510 0.085 8.843 0.264
Surgical Procedures 0.588 0.443 0.002 0.968
Tumor Diameter (cm, ≤5, > 5) 2.279 0.133 4.040 0.044
pT 1.616 0.656 11.776 0.008
pN 14.476 0.001 9.615 0.008
Pathological Differentiation 1.565 0.667 1.808 0.613
Lymph Node Metastasis 14.714 0.000 9.811 0.002
Clinical Stage 32.953 0.000 24.848 0.000
Post-op Complications 0.689 0.407 0.220 0.639
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Page 9 of 12showed no significant differences between laparoscopic
and open procedures. No significant differences in the
occurrence of port-site/wound metastases or peritoneal
metastases were observed [22,34-39]. Long-term out-
come data from three major multicenter trials are still
awaited [15,22,35]. Early results from the COST study,
with a median follow-up of 4.4 years, also did not
demonstrate any difference in tumor recurrence, dis-
ease-free survival, and overall survival rates between the
two surgical techniques for treating potentially curable
colon cancer [22]. This study also confirmed that the
laparoscopic approach can provide as good radical
resection as an open approach for treating potentially
curative colorectal cancer. Similar perioperative mortal-
ity in the two groups confirmed the clinical safety of the
laparoscopic approach reported in earlier research
[14,22,34,40]. The potential impact of laparoscopic sur-
gery on survival is not clear in this study since the mul-
tivariance analysis only indicated the clinical staging as a
high risk factor for overall survival. The role of immu-
nosuppression has been proved because of mediators of
immunologic response. This positive impact of the
laparoscopic procedure is probably worth further
investigation.
The present study was obviously limited in that the
patients were partially randomized into the two treat-
ments arms. However, these results were obtained by
two different teams specializing in respective surgical
procedures, operating at a high volume of cases. More-
over, since there were no differences in demographic
data, and all observed biases have negligible impact on
the results we believe our results are accurate. This
study has confirmed the feasibility of laparoscopic
procedures for colorectal cancer, advocating the fast
recovery times, and demonstrating similar medium-term
recurrence and survival between LAP and OP groups.
Thus, in a dedicated laparoscopic center, laparoscopic
procedures may result in a potential perioperative and
follow-up survival benefit compared with open proce-
dures, particularly in advanced cases.
Conclusions
In this original clinical research, we conclude that
laparoscopic-assisted procedures have more benefits on
postoperative recovery, while has the same effectiveness
on medium-term recurrence and survival compared
with open surgery in the treatment of non-metastatic
colorectal cancer. Thus, laparoscopic procedures may
become the most effective treatments for colorectal can-
cer in the future.
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